Gilead, Coinbase, Rocket Lab And A Tech Stock On CNBC's 'Final Trades'

On CNBC's “Halftime Report Final Trades,” Rob Sechan, CEO of NewEdge Wealth, named Gilead Sciences, Inc. (NASDAQ:GILD) as his final trade.

Lending support to his choice, Citigroup analyst Geoff Meacham maintained a Buy rating for Gilead Sciences on Oct. 8, raising the price target from $125 to $135.

Kevin Simpson, Capital Wealth Planning founder and CIO, said Rocket Lab Corporation (NASDAQ:RKLB) has a 30% year-over-year earnings growth.

Rocket Lab announced on Oct. 10 that it has signed a direct contract for two dedicated Electron launches with the Japan Aerospace Exploration Agency.

Don't forget to check out our premarket coverage here

Jason Snipe, founder and chief investment officer of Odyssey Capital Advisors, picked Palo Alto Networks, Inc. (NASDAQ:PANW) as his final trade.

Supporting his view, Tigress Financial analyst Ivan Feinseth, on Sept. 26, initiated coverage on Palo Alto Networks with a Buy rating and announced a price target of $245.

Stephanie Link, Hightower Advisors chief investment strategist and portfolio manager, named Coinbase Global, Inc. (NASDAQ:COIN).

On the earnings front, Coinbase Global will publish its third-quarter shareholder letter, which includes financial results, on Thursday, October 30, after the closing bell. Analysts expect the company to report quarterly earnings at $1.17 per share, up from 28 cents per share in the year-ago period. The company projects quarterly revenue of $1.77 billion, compared to $1.21 billion a year earlier.

Price Action:

• Gilead shares gained 0.4% to close at $117.18 on Friday.
• Rocket Lab fell 3.3% to settle at $64.26 during the session.
• Palo Alto dipped 3.1% to close at $208.55 on Friday.
• Coinbase shares jumped 6% to settle at $357.01 on Friday.

Check This Out:

• Bank of America Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street’s Most Accurate Analysts

Photo via Shutterstock